Natrecor (nesiritide) is a new IV drug in Canada for treating patients who are hospitalized with acute heart failure

Natrecor (nesiritide) is a new IV drug in Canada for treating patients who are hospitalized with acute heart failure.

It's the first in a class called human B-type natriuretic peptides. Natrecor is a recombinant version of this peptide...and has vasodilatory effects.

Natrecor improves circulation and shortness of breath.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote